Focus Stack
A two-compound research stack combining Bromantane and Semax — pairing dopaminergic and serotonergic modulation with ACTH-derived neuropeptide signalling for BDNF upregulation and cognitive enhancement research. Two of the most studied compounds in nootropic and cognitive neuroscience research, independently HPLC-verified to ≥99% purity and EU-dispatched.
In Stock
Save 18%
A two-compound research stack pairing Bromantane — a dopaminergic and serotonergic modulator studied for actoprotective and anxiolytic effects — with Semax, an ACTH-derived heptapeptide researched for BDNF upregulation, neuroprotection, and cognitive enhancement. Both compounds independently HPLC-verified to ≥99% purity and dispatched from Lithuania.
An adamantane-derived actoprotector studied for its dual modulation of dopaminergic and serotonergic systems via upregulation of tyrosine hydroxylase and tryptophan hydroxylase. Research covers anxiolytic and stimulant properties without the tolerance or dependence profiles associated with classical psychostimulants, alongside immunomodulatory and heat-resistance effects in preclinical models.
A synthetic heptapeptide analogue of the ACTH(4–7) fragment, developed and studied extensively in Russia for cognitive and neuroprotective applications. Research covers robust BDNF and NGF upregulation in the hippocampus and frontal cortex, enhanced memory consolidation, reduced neuroinflammatory markers, and neuroprotective effects in ischaemia and hypoxia models.
All compounds are supplied for laboratory and scientific research purposes only. Not for human or veterinary use. By purchasing you confirm you are a qualified researcher and understand all applicable regulations in your jurisdiction.
What the Science Studies
Bromantane and Semax represent two well-characterised but mechanistically distinct areas of cognitive and neurological research — from monoamine system modulation and actoprotection to ACTH-derived neuropeptide signalling and neurotrophic factor upregulation.